106
Views
6
CrossRef citations to date
0
Altmetric
Original Research

CircRNA CircRIMS is Overexpressed in Esophageal Squamous Cell Carcinoma and Downregulate miR-613 Through Methylation to Increase Cell Proliferation

, , , , , & show all
Pages 4587-4595 | Published online: 09 Jun 2021

References

  • Higuchi K, Koizumi W, Tanabe S, et al. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res. 2009;3(4):153–161.19742141
  • Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017;95(1):22–28.28075104
  • Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210–215. doi:10.1016/j.asjsur.2016.10.00527986415
  • Sohda M, Kuwano H. Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg. 2017;23(1):1–11. doi:10.5761/atcs.ra.16-0016228003586
  • Wu SG, Zhang WW, Sun JY, Li FY, Lin Q, He ZY. Patterns of distant metastasis between histological types in esophageal cancer. Front Oncol. 2018;8:302. doi:10.3389/fonc.2018.0030230135855
  • Ai D, Zhu H, Ren W, et al. Patterns of distant organ metastases in esophageal cancer: a Population-Based Study. J Thorac Dis. 2017;9(9):3023–3030. doi:10.21037/jtd.2017.08.7229221275
  • Huang M, Shen A, Ding J, Geng M. Molecularly targeted cancer therapy: some lessons from the past decade. Trends Pharmacol Sci. 2014;35(1):41–50. doi:10.1016/j.tips.2013.11.00424361003
  • Bozic I, Allen B, Nowak MA. Dynamics of targeted cancer therapy. Trends Mol Med. 2012;18(6):311–316. doi:10.1016/j.molmed.2012.04.00622595628
  • Joo WD, Visintin I, Mor G. Targeted cancer therapy–are the days of systemic chemotherapy numbered? Maturitas. 2013;76(4):308–314. doi:10.1016/j.maturitas.2013.09.00824128673
  • Kato H, Arao T, Matsumoto K, et al. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma. Int J Oncol. 2013;42(4):1151–1158. doi:10.3892/ijo.2013.183023426935
  • Ma S, Paiboonrungruan C, Yan T, Williams KP, Major MB, Chen XL. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci. 2018;1434(1):164–172. doi:10.1111/nyas.1368129752726
  • Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127. doi:10.1016/j.gde.2017.11.00729245064
  • Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16(2):292–301. doi:10.7150/ijms.2804730745810
  • Lin J, Zhang Y, Zeng X, Xue C, Lin X. CircRNA CircRIMS acts as a MicroRNA sponge to promote gastric cancer metastasis. ACS Omega. 2020;5(36):23237–23246. doi:10.1021/acsomega.0c0299132954174
  • Su X, Gao C, Feng X, Jiang M. miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD. Exp Ther Med. 2020;19(4):3081–3089. doi:10.3892/etm.2020.854032256796
  • Barret M, Prat F. Diagnosis and treatment of superficial esophageal cancer. Ann Gastroenterol. 2018;31(3):256–265. doi:10.20524/aog.2018.025229720850